General Information of This Metabolic Reaction (MR) (ID:
MR002086) |
Formula |
|
Reactant |
Ponatinib hydrochloride |
Product |
Ponatinib metabolite M3 |
Reactant Info
|
Product Info
|
Metabolic Type
|
Oxidation
-
Oxidtive Deamination
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Metabolize The Produtc of This MR
|
|
References |
1 |
Novel pathways of ponatinib disposition catalyzed by CYP1A1 involving generation of potentially toxic metabolites. J Pharmacol Exp Ther. 2017 Oct;363(1):12-19.
|
2 |
Absorption, metabolism, and excretion of [(14)C]ponatinib after a single oral dose in humans Cancer Chemother Pharmacol. 2017 Mar;79(3):507-518. doi: 10.1007/s00280-017-3240-x.
|
3 |
In vitro metabolites characterization of ponatinib in human liver microsomes using ultra-high performance liquid chromatography combined with Q-Exactive-Orbitrap tandem mass spectrometry Biomed Chromatogr. 2020 Jun;34(6):e4819. doi: 10.1002/bmc.4819.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.